Literature DB >> 15928381

Topical ciprofloxacin can delay recovery from viral ocular surface infection.

A Patwardhan1, M Khan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15928381      PMCID： PMC1142235          DOI： 10.1177/014107680509800610

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  5 in total

1.  Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis.

Authors:  H M Leibowitz
Journal:  Am J Ophthalmol       Date:  1991-10       Impact factor: 5.258

2.  Scanning electron microscopic study of a Ciloxan bottle blocked by ciprofloxacin crystals.

Authors:  T John
Journal:  Eye (Lond)       Date:  2001-12       Impact factor: 3.775

3.  Ciprofloxacin microprecipitates and macroprecipitates in the human corneal epithelium.

Authors:  R A Eiferman; J P Snyder; R E Nordquist
Journal:  J Cataract Refract Surg       Date:  2001-10       Impact factor: 3.351

4.  Antibacterial activity of the white precipitate formed on the corneal surface after treatment with ciprofloxacin ophthalmic solution.

Authors:  H N Madhavan; S K Rao; P R Joseph; K N Sulochana
Journal:  Cornea       Date:  1999-09       Impact factor: 2.651

5.  0.3% ciprofloxacin ophthalmic ointment in the treatment of bacterial keratitis. The Ciprofloxacin Ointment/Bacterial Keratitis Study Group.

Authors:  K R Wilhelmus; R A Hyndiuk; D R Caldwell; R L Abshire; A T Folkens; L B Godio
Journal:  Arch Ophthalmol       Date:  1993-09
  5 in total
  1 in total

1.  Medical History, Clinical Features, Treatment Outcome and Its Predictors Among Infectious Keratitis Patients in Jimma University Medical Center, Southwest Ethiopia: Prospective Observational Study.

Authors:  Tolcha Regasa Dago; Dagmawit Kifle Woldemichael; Fekede Bekele Daba
Journal:  Clin Ophthalmol       Date:  2021-03-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.